Schmid John P.
SEC CIK 1478916 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLSM | BlossomHill Therapeutics, Inc. | Dir | 6,000 | $96.0K | — | 1 | 2026-08-10 | 2026-08-10 |
| TRAX | First Tracks Biotherapeutics, Inc. | Dir | 37.7K | — | — | 1 | 2026-06-15 | 2026-06-15 |
| ANAB | ANAPTYSBIO, INC | Dir | 37.7K | — | $1.16M | 7 | 2024-06-15 | 2026-06-15 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Former Dir | 30.0K | — | — | 1 | 2025-08-11 | 2025-08-11 |
| XERS | Xeris Biopharma Holdings, Inc. | Dir | 25.2K | $50.2K | — | 9 | 2021-10-05 | 2024-08-12 |
| DSGN | Design Therapeutics, Inc. | Dir | 9,156 | $99.8K | — | 1 | 2024-03-22 | 2024-03-22 |
Most active insiders at BLSM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORDON CARL L | Dir | $10.00M | — |
| 2 | ORBIMED ADVISORS LLC | Dir | $10.00M | — |
| 3 | Chen Bihua | Dir, 10% | $5.00M | — |
| 4 | Schmid John P. | Dir | $96.0K | — |
| 5 | Liptak Vincent Paul | GC | $74.7K | — |
| 6 | Keyes Jason A | CFO | $11.2K | — |
| 7 | Agrawal Sundeep | Dir | — | — |
| 8 | Cui Jingrong Jean | Pres, CEO, Dir, 10% | — | — |
| 9 | Li Yishan | Executive COB, Dir, 10% | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 18:35 | 2026-08-10 | BLSM | BlossomHill Therapeutics, Inc. | Schmid John P. | Dir | P - Purchase | $16.00 | +6,000 | 6,000 | New | +$96.0K | |
| D | 2026-06-17 16:05 | 2026-06-15 | TRAX | First Tracks Biotherapeutics, Inc. | Schmid John P. | Dir | M - OptEx | $0.00 | +6,030 | 37.7K | +19% | $0 |
| D | 2026-06-17 16:05 | 2026-06-15 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | M - OptEx | $0.00 | +6,030 | 37.7K | +19% | $0 |
| M | 2026-04-01 21:28 | 2026-03-30 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | S - Sale | $56.11 | -20.6K | 31.6K | -39% | -$1.16M |
| I | 2025-12-23 | 2025-12-23 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | J - Other | $51.00 | -11.1K | 0 | -100% | -$564.5K |
| D | 2025-08-11 | 2025-08-11 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Schmid John P. | Former Dir | M - OptEx | — | +30.0K | 30.0K | New | — |
| D | 2025-06-17 | 2025-06-15 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | M - OptEx | $0.00 | +6,030 | 52.3K | +13% | $0 |
| I | 2025-03-27 | 2025-03-25 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | J - Other | $18.18 | +11.1K | 11.1K | New | +$201.2K |
| DM | 2025-01-15 | 2025-01-13 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | M - OptEx | $6.50 | +42.3K | 25.6K | New | +$275.0K |
| I | 2024-08-13 | 2024-08-12 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | P - Purchase | $2.25 | +4,515 | 25.2K | +22% | +$10.2K |
| I | 2024-08-12 | 2024-08-09 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | P - Purchase | $2.37 | +4,285 | 20.7K | +26% | +$10.2K |
| D | 2024-06-18 | 2024-06-15 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Dir | M - OptEx | $0.00 | +3,900 | 3,900 | New | $0 |
| 2024-06-05 | 2024-06-05 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | A - Grant | $0.00 | +50.0K | 113.2K | +79% | $0 | |
| I | 2024-05-10 | 2024-05-10 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | P - Purchase | $1.91 | +5,400 | 16.4K | +49% | +$10.3K |
| MI | 2024-03-25 | 2024-03-22+ | DSGN | Design Therapeutics, Inc. | Schmid John P. | Dir | P - Purchase | $3.70 | +27.0K | 9,156 | New | +$99.8K |
| I | 2024-03-14 | 2024-03-14 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | P - Purchase | $2.16 | +4,500 | 11.0K | +69% | +$9,720 |
| I | 2023-11-17 | 2023-11-16 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | P - Purchase | $1.51 | +6,500 | 6,500 | New | +$9,815 |
| 2023-06-07 | 2023-06-07 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | A - Grant | $0.00 | +42.5K | 63.2K | +206% | $0 | |
| D | 2022-06-09 | 2022-06-08 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | A - Grant | $0.00 | +15.0K | 20.7K | +265% | $0 |
| D | 2021-10-05 | 2021-10-05 | XERS | Xeris Biopharma Holdings, Inc. | Schmid John P. | Dir | A - Grant | — | +5,659 | 5,659 | New | — |
Purchase Sale Sale after option exercise All abbreviations